Two medtechs advance with regulatory approvals 17.08.2026 17:01 Geneva-based Spineart and Vaud-based Distalmotion have each cleared a new regulatory hurdle for their surgical technologies. Spineart has received U.S. Food and Drug Administration (FDA) approval for its cervical disc replacement system, while Distalmotion has received FDA clearance for its surgical robot for ventral hernia repair.